Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

HIV can cause unusual and severe skin problems that are hard to treat.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Somatostatin may help protect hair follicles from immune attacks.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hair repigmentation can indicate malignancy and should be investigated.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.